Sanai Health Industry Group Company Limited (SEHK: 1889)
Health Care · Pharmaceuticals · HK
HK$0.16
-8.24% today · -64.1% 1Y
Sanai Health Industry Group Company Limited (SEHK: 1889) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.04M and employs 160 people.
Over the last twelve months the share price has lost 64.1%, trading between 0.13 and 0.65.
Tweenvest scores Sanai Health Industry Group Company Limited across four factors: quality 56/100, value 60/100, growth 0/100. Its strongest factor is value.
1889 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.04M
- Revenue (TTM)
- $12.28M
- P/E
- —
- EPS
- -0.14
- Dividend yield
- —
- Beta (5Y)
- -1.51
- 52-week high
- HK$0.65
- 52-week low
- HK$0.13
- Avg volume (3M)
- —
- Shares outstanding
- 152.90M
- Employees
- 160
- Next earnings
- —
About Sanai Health Industry Group Company Limited
Sanai Health Industry Group Co. Ltd. is an investment holding company, which engaged in branded prescription and non-prescription drugs. It operates through the following segments: Pharmaceutical Products, Finance Leasing, and Genetic Testing and Molecular Diagnostic Services. The Pharmaceutical Products segment engages in development, manufacturing, marketing, and sales of pharmaceutical products. The company was founded on March 21, 2006 and is headquartered in Hong Kong.
- ISIN
- KYG7785S1158
- Founded
- 2006
- Listed since
- Jan 31, 2007
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.